本文選題：早發(fā)性帕金森病 + 晚發(fā)性帕金森病　； 參考：《浙江大學(xué)》2017年博士論文

【摘要】：研究背景原發(fā)性帕金森病(idiopathic Parkinson's disease,簡(jiǎn)稱帕金森病)是一種常見(jiàn)的中樞神經(jīng)系統(tǒng)退行性疾病,其主要表現(xiàn)為運(yùn)動(dòng)功能的損害,以靜止性震顫、肌強(qiáng)直、運(yùn)動(dòng)遲緩、姿勢(shì)步態(tài)異常為其四大運(yùn)動(dòng)主征,同時(shí)還可能伴有認(rèn)知功能損害、抑郁等非運(yùn)動(dòng)癥狀。通常帕金森病患者的發(fā)病年齡為55-60歲,在40歲(部分文獻(xiàn)定義為50歲)以前就出現(xiàn)首個(gè)帕金森癥狀的被稱為早發(fā)性帕金森病(Early-onset Parkinson's disease,EOPD)。EOPD患者的臨床表現(xiàn)與晚發(fā)性帕金森病(Late-onset Parkinson's disease,LOPD)大體相似,但該類患者仍具有其特殊的臨床表現(xiàn)及疾病進(jìn)展特征。例如,EOPD患者對(duì)多巴制劑療效反應(yīng)較好,疾病進(jìn)展較LOPD緩慢,但更多更早的出現(xiàn)運(yùn)動(dòng)困難、肌張力障礙、運(yùn)動(dòng)波動(dòng)等運(yùn)動(dòng)并發(fā)癥。不僅如此,在非運(yùn)動(dòng)癥狀上也存在差異,例如EOPD患者認(rèn)知障礙發(fā)生率小于LOPD患者,但抑郁癥狀發(fā)生率卻明顯高于LOPD患者。盡管對(duì)EOPD與LOPD這些臨床差異的研究結(jié)果比較明確,但造成這種差異的原因目前仍不清楚。近年來(lái)神經(jīng)影像學(xué)技術(shù)被越來(lái)越多的運(yùn)用于EOPD與LOPD患者的研究。采用核素成像技術(shù)通過(guò)對(duì)兩類患者黑質(zhì)紋狀體區(qū)域突觸層面進(jìn)行多巴胺能示蹤的研究結(jié)果較為矛盾,卻仍然為這兩類患者的疾病異質(zhì)性提供了腦內(nèi)線索。但核素成像技術(shù)具有放射性,且研究多局限于黑質(zhì)或紋狀體核團(tuán)的成像,忽略了患者腦內(nèi)其他部位結(jié)構(gòu)功能改變對(duì)疾病的影響。磁共振成像技術(shù)彌補(bǔ)了這些缺陷,目前已有部分文獻(xiàn)應(yīng)用該技術(shù)對(duì)EOPD與LOPD患者展開(kāi)研究。研究發(fā)現(xiàn)伴有左旋多巴引起的異動(dòng)癥的EOPD與LOPD患者大腦灰質(zhì)體積增加區(qū)域不同。而通過(guò)測(cè)量組織弛豫速率發(fā)現(xiàn)EOPD及LOPD患者在基底節(jié)核團(tuán)及黑質(zhì)的腦鐵變化不同,近年的兩項(xiàng)fMRI研究發(fā)現(xiàn)該兩類患者腦功能還存在差異。這些研究提示了 EOPD與LOPD兩類患者腦內(nèi)結(jié)構(gòu)、功能、代謝可能存在差異,且這種差異可能并不僅存在于中腦及基底節(jié)核團(tuán),還可能廣泛的存在于皮層組織,而磁共振成像技術(shù)是檢測(cè)這些差異的有效手段。研究發(fā)現(xiàn)小腦不僅和震顫、多巴制劑引起的異動(dòng)癥等運(yùn)動(dòng)癥狀及認(rèn)知功能損害等非運(yùn)動(dòng)癥狀的產(chǎn)生有關(guān),可能還對(duì)基底節(jié)區(qū)的多巴胺能損傷起補(bǔ)償作用。因此小腦可能在帕金森病中同時(shí)起病理及代償?shù)碾p重作用,近年來(lái)已經(jīng)成為研究帕金森病的又一重要靶點(diǎn)。綜上,本研究將采用多模態(tài)磁共振技術(shù)對(duì)EOPD與LOPD患者的腦鐵代謝、腦結(jié)構(gòu)尤其是小腦結(jié)構(gòu),以及靜息狀態(tài)下的腦網(wǎng)絡(luò)功能連接展開(kāi)研究,探索兩類患者腦內(nèi)代謝、結(jié)構(gòu)、功能的差異及其與臨床特征的相關(guān)性。方法實(shí)驗(yàn)一:以發(fā)病年齡50歲為分界點(diǎn),我們將納入的帕金森病患者分為EOPD(35人)與LOPD(33人)組,并同時(shí)納入分別與之相對(duì)應(yīng)的對(duì)照組(年輕對(duì)照24人,年老對(duì)照22人),進(jìn)行臨床評(píng)估及ESWAN序列掃描。將獲得的相位圖采用定量磁敏感圖技術(shù)進(jìn)行重建并獲得磁化率圖。選取兩側(cè)蒼白球、殼核、尾狀核頭部、黑質(zhì)致密部(SNc)、黑質(zhì)網(wǎng)狀部(SNr)以及紅核為感興趣區(qū),采用手繪感興趣區(qū)方式進(jìn)行磁化率測(cè)量,獲得每個(gè)感興趣的定量腦鐵含量信息。分析患者與對(duì)應(yīng)正常對(duì)照之間的腦鐵含量差異及其與臨床信息的關(guān)系。實(shí)驗(yàn)二:分別納入EOPD(28人)、LOPD(37人)及與之相對(duì)應(yīng)的對(duì)照組各23人,進(jìn)行臨床評(píng)估并采集3D結(jié)構(gòu)像。受試者圖像采用基于體素的形態(tài)學(xué)分析(VBM)技術(shù)進(jìn)行全腦結(jié)構(gòu)分析,其中配準(zhǔn)技術(shù)采用DARTEL算法,采用6mm全寬半高高斯核進(jìn)行平滑。平滑后的圖像控制年齡、性別后在SPM8軟件上進(jìn)行統(tǒng)計(jì)分析獲得患者與其相應(yīng)對(duì)照的全腦結(jié)構(gòu)改變信息,并進(jìn)行后期臨床相關(guān)分析。實(shí)驗(yàn)三:納入EOPD(31人)、LOPD(39人)及與之相對(duì)應(yīng)的對(duì)照組各23人,進(jìn)行臨床評(píng)估并采集3D結(jié)構(gòu)像。圖像預(yù)處理在SPM8軟件上進(jìn)行,所有受試者圖像沿前后聯(lián)合進(jìn)行手工原點(diǎn)重定位,采用SUIT工具包將T1加權(quán)圖像進(jìn)行分割,得到僅包括幕下組織的圖像,分割后的灰質(zhì)圖像空間標(biāo)準(zhǔn)化至SUIT模板,然后進(jìn)行空間重采樣,最后采用6mm的全寬半高高斯核進(jìn)行平滑。在進(jìn)行平滑步驟前,對(duì)每個(gè)受試者小腦總體積進(jìn)行計(jì)算。患者與其相對(duì)應(yīng)的對(duì)照組預(yù)處理后的圖像以年齡、性別及小腦總體積為協(xié)變量進(jìn)行兩樣本t檢驗(yàn),獲得小腦結(jié)構(gòu)改變信息,并進(jìn)行臨床相關(guān)分析。實(shí)驗(yàn)四:納入EOPD(29人)、LOPD(33人)及與之相對(duì)應(yīng)的對(duì)照組(年輕對(duì)照22人,年老對(duì)照23人),進(jìn)行臨床評(píng)估并進(jìn)行靜息態(tài)功能磁共振掃描,使用DPARSF軟件包對(duì)采集的靜息態(tài)功能磁共振圖像進(jìn)行標(biāo)準(zhǔn)化的圖像數(shù)據(jù)預(yù)處理,其中每個(gè)受試者的前10個(gè)時(shí)間點(diǎn)的腦圖像被舍棄,圖像平滑采用6mm的全寬半高高斯核進(jìn)行平滑。使用Group ICA/IVA of fMRI Toolbox(GIFT)軟件工具平臺(tái)對(duì)平滑后的數(shù)據(jù)進(jìn)行數(shù)據(jù)驅(qū)動(dòng)的獨(dú)立成分分析,設(shè)置成分?jǐn)?shù)為24,根據(jù)Smith等學(xué)者研究報(bào)道選取最為匹配的DMN與DAN網(wǎng)絡(luò)。以年齡、性別為協(xié)變量對(duì)比患者與其相對(duì)應(yīng)的對(duì)照組間DAN與DMN網(wǎng)絡(luò)內(nèi)功能連接情況,并進(jìn)行臨床相關(guān)分析。結(jié)果實(shí)驗(yàn)一:與YC組對(duì)比,EOPD患者在SNc(P =0.004)以及SNr(P =0.009)磁化率增高,表明EOPD患者在該兩個(gè)核團(tuán)腦鐵含量增高。而在LOPD組,不僅SNc(P =0.002)、SNr(P =0.032)兩個(gè)部位磁化率增高,殼核(P =0.020)的磁化率也出現(xiàn)增高。LOPD患者SNc的磁化率值與HY分級(jí)、UPDRS第二部分評(píng)分呈正相關(guān);而SNr的磁化率值與UPDRS第二部分評(píng)分呈正相關(guān);而殼核的磁化率值與UPDRS第二部分評(píng)分Ⅱ,UPDRS第三部分評(píng)分呈正相關(guān)。EOPD患者中未發(fā)現(xiàn)腦鐵含量增高與臨床信息的相關(guān)性。實(shí)驗(yàn)二:與YC組相比,EOPD患者在左側(cè)殼核、額下回及島葉以及腦干的灰質(zhì)密度減低,在右側(cè)枕葉與兩側(cè)小腦后葉灰質(zhì)密度增加。而與OC組相比,LOPD患者在左側(cè)小腦后葉、左側(cè)枕葉、腦干及右側(cè)輔助運(yùn)動(dòng)區(qū)灰質(zhì)密度減低,而在左側(cè)顳中回灰質(zhì)密度增加。兩組患者具有組間差異的腦區(qū)灰質(zhì)密度未發(fā)現(xiàn)與臨床信息有統(tǒng)計(jì)學(xué)相關(guān),但是在EOPD患者組,增加的右側(cè)小腦灰質(zhì)密度與減低的腦干灰質(zhì)密度相關(guān)(P=0.029,r=-0.428)。實(shí)驗(yàn)三:以PFDR0.05為統(tǒng)計(jì)學(xué)上有顯著性差異。LOPD與其對(duì)應(yīng)的OC組之間未發(fā)現(xiàn)有顯著性差異的腦區(qū)。而EOPD組與其對(duì)應(yīng)的YC相比,在兩側(cè)齒狀核灰質(zhì)體積減少,而在兩側(cè)半球的Ⅶb、Ⅶa、CrusⅡ灰質(zhì)體積增加。在EOPD患者組中,右側(cè)半球外側(cè)的Ⅶb與Ⅷa區(qū)域灰質(zhì)體積分別與患者病程(Ⅶb:P=0.045,r=0.381;Ⅷa:P=0.046,r=0.381)、UPDRS 評(píng)分(Ⅶb:P=0.024,r=0.425;Ⅷa:P=0.020,r=0.437)及 HAMD 評(píng)分(Ⅶb:P=0.018,r=0.442;Ⅷa:P=0.010,r=0.478)呈正相關(guān)。實(shí)驗(yàn)四:與相應(yīng)的正常對(duì)照相比,EOPD與LOPD患者DAN網(wǎng)絡(luò)都出現(xiàn)主要節(jié)點(diǎn)的功能連接減低,但EOPD患者DAN網(wǎng)絡(luò)功能連接降低區(qū)域位于左側(cè)頂葉(頂上小葉/楔前葉),而LOPD患者DAN網(wǎng)絡(luò)功能連接降低區(qū)域位于右側(cè)額葉視區(qū)及左側(cè)小腦后葉。同樣與相應(yīng)的正常對(duì)照相比,EOPD患者DM[N的兩側(cè)楔前葉/后扣帶回皮層功能連接降低,LOPD患者DMN兩側(cè)背內(nèi)側(cè)前額葉皮層功能連接降低。兩組患者DAN、DMN功能連接降低區(qū)域在本研究中未發(fā)現(xiàn)與兩類患者臨床評(píng)分存在統(tǒng)計(jì)學(xué)相關(guān)關(guān)系。但是在EOPD患者中DAN減低區(qū)域的功能連接與DMN減低區(qū)域的功能連接呈正相關(guān)(P=0.030,r=0.434)。結(jié)論綜上所述,我們的研究顯示:(1)EOPD與LOPD患者具有發(fā)病年齡相關(guān)的不同腦鐵沉積模式。(2)EOPD患者與LOPD患者腦內(nèi)灰質(zhì)密度改變模式存在不同。尤其小腦部位,在兩類患者中所起的作用可能不同:在兩類患者中不僅起病理作用,在EOPD患者中可能起重要的代償作用,從而減緩了 EOPD患者疾病的進(jìn)展,但同時(shí)也可能導(dǎo)致了其運(yùn)動(dòng)并發(fā)癥的發(fā)生率增高。(3)EOPD與LOPD患者都存在DMN、DAN網(wǎng)絡(luò)節(jié)點(diǎn)功能連接降低現(xiàn)象,但EOPD患者功能連接降低都位于網(wǎng)絡(luò)的關(guān)鍵節(jié)點(diǎn),提示該類患者這兩個(gè)網(wǎng)絡(luò)功能損害可能更甚于LOPD患者。同時(shí)在EOPD患者中,DAN與DMN關(guān)鍵節(jié)點(diǎn)功能連接減低呈正相關(guān),我們推測(cè)可能反應(yīng)了該類患者靜息狀態(tài)下大腦整體功能水平出現(xiàn)減低,但該推測(cè)目前仍需進(jìn)一步研究證實(shí)。
[Abstract]:Background primary Parkinson's disease (idiopathic Parkinson's disease, referred to as Parkinson's disease) is a common degenerative disease of the central nervous system, which is mainly manifested in motor function damage, with static tremor, myotonic, slow motion, and postural gait abnormalities as its four major motor signs, and may also be accompanied by cognitive impairment. Non motor symptoms, such as injury, depression, and so on. Usually the onset age of patients with Parkinson's disease is 55-60 years old, and the first Parkinson symptom (Early-onset Parkinson's disease, EOPD).EOPD patients with the first Parkinson symptom before the age of 50 years old (Late-onset Parkinson's DI) Sease, LOPD) are generally similar, but these patients still have special clinical manifestations and characteristics of disease progression. For example, EOPD patients respond better to DOPA preparation, disease progression is slower than LOPD, but more early symptoms of motor complications such as dyskinesia, dystonia, movement fluctuations, and not only so, but also in non motor symptoms. Differences, for example, the incidence of cognitive impairment in EOPD patients is less than that of LOPD patients, but the incidence of depressive symptoms is significantly higher than that of LOPD patients. Although the results of these differences between EOPD and LOPD are more clear, the reasons for this difference are still unclear. In recent years, neuroimaging techniques have been used more and more in EOPD and LOPD The results of radionuclide imaging of two groups of patients with dopamine tracers at the synaptic layer in the substantia nigra region are relatively contradictory, but still provide intracerebral clues for the heterogeneity of the two types of patients. However, the radionuclide imaging technology is radioactive, and the research is limited to the formation of the substantia nigra or the striatum. Like, neglecting the effects of structural changes in other parts of the brain on the disease. Magnetic resonance imaging technology has made up for these defects. Currently, some literature has been used to study EOPD and LOPD patients. The study found that EOPD and LOPD patients with levodopa induced dyskinesia have different areas of gray matter volume in the brain. The changes in the basal ganglia and substantia nigra of the EOPD and LOPD patients were detected by measuring the tissue relaxation rate. In recent years, two fMRI studies found differences in the brain function of the two types of patients. These studies suggest that there may be differences in the structure, function, and metabolism of the brain in the EOPD and LOPD two patients, and this difference may not only exist. Magnetic resonance imaging is an effective means to detect these differences in the mesencephalon and basal ganglia nuclei, and magnetic resonance imaging is an effective means to detect these differences. It is found that the cerebellum is not only associated with the onset of motor symptoms, such as dyskinesia caused by dopa preparations, and impairment of cognitive function, but also the dopamine in the basal ganglia region. The cerebellum may play a compensatory role. Therefore, the cerebellum may play a double role of pathology and compensation in Parkinson's disease. In recent years, it has become another important target for the study of Parkinson's disease. To sum up, this study will use multimodal magnetic resonance (MRI) technique for the brain iron metabolism, the structure of the brain, especially the cerebellar structure, and resting state in the patients with EOPD and LOPD. Study on brain network functional connection to explore the difference in brain metabolism, structure, function and its correlation with clinical characteristics in two types of patients. Method Experiment 1: We divided the patients with Parkinson's disease into EOPD (35) and LOPD (33 people) with the age of onset at the age of 50, and included the corresponding control group (young). The clinical evaluation and ESWAN sequence scan were performed in 24 people, aged 22 people. The obtained phase maps were reconstructed with magnetic susceptibility mapping and obtained the magnetic susceptibility map. The two sides of the globus pallidus, the putamen, the caudate nucleus, the dense part of the substantia nigra (SNc), the substantia nigra reticularis (SNr) and the red nucleus were selected as the region of interest, and the hand-painted area of interest was used. Measurement of magnetic susceptibility, obtain each interesting quantitative brain iron content information. Analyze the difference of brain iron content between patients and corresponding normal controls and their relationship with clinical information. Experiment two: EOPD (28 people), LOPD (37 people) and the corresponding control group of 23 people, clinical evaluation and collection of 3D structure. The whole brain structure analysis was performed using the Morphin based morphological analysis (VBM) technique, in which the registration technique used the DARTEL algorithm and the 6mm full width half high Gauss kernel to smooth. The smooth image was used to control the age. After sex, the statistical analysis of the whole brain structure was obtained on the SPM8 software. Clinical correlation analysis. Experiment three: EOPD (31 people), LOPD (39 people) and the corresponding control group of 23 people, clinical evaluation and collection of 3D structure image. Image preprocessing on the SPM8 software, all the subjects image along the joint manual repositioning, using the SUIT toolkit to segment T1 weighted images, get only The image of the sub episodes, the gray matter image space after the segmentation is standardized to the SUIT template, then the space is resampling, and then the full width half of the Gauss kernel of the 6mm is used to smooth. The total volume of the cerebellum is calculated before the smoothing step. Two samples t test was carried out with the total volume of the cerebellum to obtain the information of the changes in the cerebellum structure and to carry out clinical correlation analysis. Experiment four: included in the EOPD (29 people), LOPD (33 people) and the corresponding control group (22 young control, aged 23 people), performed bed assessment and performed resting state functional magnetic resonance scanning, using DPARSF software The packet has standardized image data preprocessing for the collected resting functional magnetic resonance image, in which the brain images of the first 10 time points of each subject are abandoned and the image smoothing is smooth using the full width half of the Gauss kernel of 6mm. The smooth data is processed using the Group ICA/IVA of fMRI Toolbox (GIFT) software tool platform. The independent component analysis, set up as 24, selected the most matched DMN and DAN network according to the Smith and other scholars, compared the functional connection between the DAN and DMN networks between the patients and the corresponding control groups with age, sex and the corresponding control group, and carried out clinical correlation analysis. Results Experiment 1: compared with the YC group, EOPD patients were in SN. The increased magnetic susceptibility of C (P =0.004) and SNr (P =0.009) showed that the content of iron in the two nuclei increased in EOPD patients. In LOPD group, not only SNc (P =0.002), but also the magnetic susceptibility of the two parts of the SNr was increased, and the magnetic susceptibility of the putamen was also higher than that of the second part. The magnetic susceptibility of R was positively correlated with the score of UPDRS second, while the magnetic susceptibility of the putamen was associated with the UPDRS second part score II, and the score of the UPDRS third was positively correlated with the correlation between the increased iron content in the.EOPD patients and the clinical information. Experiment two: compared with the YC group, the EOPD patients were in the left putamen, the lower frontal gyrus and insula, and the brain stem. Gray matter density increased in the right occipital and posterior cerebellar leaves. Compared with the OC group, the gray matter density in the left posterior cerebellar, left occipital lobe, brain stem and right auxiliary motor area decreased in the left left cerebellar, while the gray matter density in the left temporal lobe was increased in the left temporal region. The gray matter density in the two groups was not found in the two groups. There was a statistically significant correlation, but in the EOPD group, the increased right cerebellar gray matter density was associated with the reduced density of the brainstem gray matter (P=0.029, r=-0.428). Experiment three: there was no significant difference between the.LOPD and the corresponding OC group with the significant difference between the PFDR0.05 and the corresponding OC group, while the EOPD group was on both sides compared with the corresponding YC. The volume of gray matter in the dentate nucleus was reduced, while the Volume VII B, VII a, and Crus II gray matter increased in both hemispheres. In the EOPD patients group, the volume of gray matter in the lateral side of the right hemisphere was respectively with the patient's course of disease (VII b:P=0.045, r=0.381; VIII a:P=0.046, r=0.381), and UPDRS score (VII b:P=0.024, VIII. .018, r=0.442, VIII, r=0.478) were positively correlated. Experiment four: compared with the corresponding normal controls, the DAN network of the EOPD and LOPD patients had the functional connection of the main nodes, but the DAN network functional connection in EOPD patients was located in the left parietal lobe (upper lobule / anterior wedge), while LOPD patients were located in the DAN network function connection area. In the right frontal lobes and the left posterior cerebellar lobe, the functional connection between the two sides of the EOPD patient's DM[N and the posterior cingulate cortex of the posterior cingulate cortex of the EOPD patients was lower than that of the corresponding normal control. The function connection of the medial prefrontal cortex in the DMN side of the two sides of the LOPD patients was reduced. The two groups of patients were not found in this study with the two types of patients in this study. There was a statistically significant correlation in the score, but the functional connection of the DAN reduction region in the EOPD patients was positively correlated with the functional connectivity of the DMN reduction region (P=0.030, r=0.434). Conclusion in conclusion, our study showed that (1) EOPD and LOPD patients have different age related age related cerebral iron deposition patterns. (2) EOPD patients and LOPD patients in the brain ash The pattern of mass density change is different, especially in the cerebellum, which may play a different role in the two types of patients: not only in the two type of patients, but also in the EOPD patients, which may play an important compensatory role, thus slowing the progression of the disease in EOPD patients, but also may lead to the increase in the incidence of sports complications. (3) EOPD In patients with LOPD, there are DMN, DAN network node dysfunction, but the function connection reduction of EOPD patients is located at the key node of the network, suggesting that these two network functions may be more impaired than those of LOPD patients. In EOPD patients, DAN and DMN key nodes have a positive correlation with the reduction of energy connections. We speculate possible responses. The overall functional level of the brain in these patients decreased at rest, but this prediction still needs further study.

【學(xué)位授予單位】：浙江大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2017
【分類號(hào)】：R742.5;R445.2

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 劉焯霖;帕金森病的診治體會(huì)[J];新醫(yī)學(xué);2000年10期

2 張巍,雷征霖,孫秀蘭,宋春莉;血管性帕金森綜合征與帕金森病患者的臨床對(duì)比分析[J];中華神經(jīng)科雜志;2000年05期

3 劉萍,邊強(qiáng);尼古丁有助于帕金森病治療[J];國(guó)外醫(yī)藥(合成藥 生化藥 制劑分冊(cè));2000年04期

4 王建,劉焯霖;帕金森病病因的新線索[J];國(guó)外醫(yī)學(xué)(內(nèi)科學(xué)分冊(cè));2000年04期

5 覃艷玲;帕金森病患者的護(hù)理體會(huì)[J];廣西醫(yī)科大學(xué)學(xué)報(bào);2000年S1期

6 侯強(qiáng),于長(zhǎng)本;帕金森病伴發(fā)的抑郁[J];臨床精神醫(yī)學(xué)雜志;2000年06期

7 張巍,梁戰(zhàn)華,雷征霖;肌萎縮側(cè)索硬化癥合并帕金森病1例報(bào)告[J];臨床神經(jīng)病學(xué)雜志;2000年03期

8 莊立;帕金森病的癥狀前指標(biāo)[J];現(xiàn)代康復(fù);2000年02期

9 劉泉開(kāi);帕金森病治療的新進(jìn)展[J];現(xiàn)代診斷與治療;2000年02期

10 于嘉;帕金森病與臨床用藥[J];首都醫(yī)藥;2000年12期

相關(guān)會(huì)議論文 前10條

1 鄒密;;老年帕金森病患者跌倒的危險(xiǎn)因素及護(hù)理干預(yù)[A];中華護(hù)理學(xué)會(huì)全國(guó)第12屆老年護(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2009年

2 康婧;羅曉光;任艷;何志義;;應(yīng)激誘發(fā)帕金森病的相關(guān)因素分析[A];中華醫(yī)學(xué)會(huì)第十三次全國(guó)神經(jīng)病學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2010年

3 李友海;田仰華;陳先文;汪凱;;帕金森病患者的時(shí)間感知研究[A];中華醫(yī)學(xué)會(huì)第十三次全國(guó)神經(jīng)病學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2010年

4 李如奎;;帕金森病研究進(jìn)展[A];第三屆全國(guó)中西醫(yī)結(jié)合神經(jīng)系統(tǒng)疾病學(xué)術(shù)會(huì)議論文集[C];2000年

5 楊曉軍;李筱婷;;從中醫(yī)角度探討帕金森病[A];中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)成立20周年紀(jì)念大會(huì)論文集[C];2001年

6 周文泉;于向東;;對(duì)帕金森病研究的思索[A];第三次全國(guó)中西醫(yī)結(jié)合養(yǎng)生學(xué)與康復(fù)醫(yī)學(xué)學(xué)術(shù)研討會(huì)論文集[C];2002年

7 韓蓉蓉;范亞瑜;吳集雄;徐曉華;劉漢偉;;帕金森病特殊類型的植物神經(jīng)功能障礙——食性低血壓[A];中華醫(yī)學(xué)會(huì)第七次全國(guó)神經(jīng)病學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2004年

8 歐陽(yáng)荔莎;;進(jìn)行性核上性麻痹誤診為帕金森病1例[A];全國(guó)外科、神經(jīng)內(nèi)外科護(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2006年

9 干靜;周明珠;劉振國(guó);陳偉;陸麗霞;吳佳英;;帕金森病患者自主神經(jīng)功能障礙評(píng)估[A];第十一屆全國(guó)神經(jīng)病學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2008年

10 史新沖;張祥松;易暢;;~(18)F-FDG PET/CT顯像在帕金森病診斷中的應(yīng)用[A];中華醫(yī)學(xué)會(huì)第九次全國(guó)核醫(yī)學(xué)學(xué)術(shù)會(huì)議論文摘要匯編[C];2011年

相關(guān)重要報(bào)紙文章 前10條

1 范又;如何早期發(fā)現(xiàn)帕金森病[N];光明日?qǐng)?bào);2006年

2 羅剛;近八成帕金森病患者看病不及時(shí)[N];健康報(bào);2007年

3 蔣雨平;帕金森病認(rèn)識(shí)四誤區(qū)[N];家庭醫(yī)生報(bào);2007年

4 孫燕明;帕金森病患者要嚴(yán)防抑郁[N];中國(guó)消費(fèi)者報(bào);2007年

5 程守勤 蔣廷玉;帕金森病發(fā)病率居高不下[N];新華日?qǐng)?bào);2006年

6 楊鋒;及早防范帕金森病[N];醫(yī)藥經(jīng)濟(jì)報(bào);2006年

7 李尤佳;帕金森病——中老年人的“絆腳石”[N];中國(guó)中醫(yī)藥報(bào);2006年

8 劉衛(wèi)宏;帕金森病并非老年人的“專利”[N];中國(guó)中醫(yī)藥報(bào);2007年

9 ;科學(xué)家發(fā)現(xiàn)：帕金森病早期確診新法[N];新華每日電訊;2008年

10 程守勤;六成帕金森病人治療不規(guī)范[N];健康報(bào);2008年

相關(guān)博士學(xué)位論文 前10條

1 王敏;帕金森病患者的輔助診斷與手運(yùn)動(dòng)補(bǔ)償研究[D];華東理工大學(xué);2012年

2 黃思菲;快動(dòng)眼期睡眠行為障礙和帕金森病患者嗅覺(jué)分析及價(jià)值[D];復(fù)旦大學(xué);2014年

3 高靚;CCL2在帕金森病輕度認(rèn)知功能障礙中的作用及機(jī)制研究[D];南方醫(yī)科大學(xué);2015年

4 谷有全;TLR4在帕金森病小鼠中腦的表達(dá)及其對(duì)炎癥介質(zhì)釋放的影響[D];南方醫(yī)科大學(xué);2014年

5 李紅燕;早發(fā)型帕金森病患者的臨床特征及維吾爾族早發(fā)型家族性帕金森病PARKIN基因突變的研究[D];安徽醫(yī)科大學(xué);2014年

6 胡盼盼;帕金森病患者的認(rèn)知神經(jīng)心理學(xué)研究[D];安徽醫(yī)科大學(xué);2014年

7 劉崴;帕金森病LRRK2和VPS35基因突變研究[D];天津醫(yī)科大學(xué);2012年

8 康文巖;α-突觸共核蛋白在帕金森病發(fā)病機(jī)制及生物學(xué)標(biāo)記物中的研究[D];上海交通大學(xué);2012年

9 李桂花;新疆地區(qū)帕金森病危險(xiǎn)因素、癥狀學(xué)和ATP13A2基因多態(tài)性研究[D];新疆醫(yī)科大學(xué);2015年

10 劉杰;γ-氨基丁酸(GABA)遞質(zhì)系統(tǒng)相關(guān)藥物在帕金森病中的作用研究[D];復(fù)旦大學(xué);2014年

相關(guān)碩士學(xué)位論文 前10條

1 康婧;應(yīng)激誘發(fā)帕金森病的相關(guān)因素分析[D];中國(guó)醫(yī)科大學(xué);2010年

2 常崇旺;人工神經(jīng)網(wǎng)絡(luò)模型診斷帕金森病的研究[D];第四軍醫(yī)大學(xué);2004年

3 陳伏祥;帕金森病輕度認(rèn)知障礙患者腦灰質(zhì)改變研究[D];福建醫(yī)科大學(xué);2015年

4 韓薇;α-突觸核蛋白(SNCA)基因多態(tài)性與帕金森病易感性的meta分析[D];河北醫(yī)科大學(xué);2015年

5 王倩;帕金森病患者自主神經(jīng)功能的研究[D];河北醫(yī)科大學(xué);2015年

6 劉疏影;不同帕金森病亞型（早發(fā)晚發(fā)型）的多巴胺轉(zhuǎn)運(yùn)體顯像特征分析[D];復(fù)旦大學(xué);2014年

7 徐睿鑫;楊明會(huì)教授治療帕金森病學(xué)術(shù)經(jīng)驗(yàn)研究[D];中國(guó)人民解放軍醫(yī)學(xué)院;2015年

8 李洋;帕金森病患者嗅覺(jué)相關(guān)腦區(qū)的MRI研究[D];蘇州大學(xué);2015年

9 李玲;早期帕金森病患者視網(wǎng)膜及視野改變的臨床研究[D];蘇州大學(xué);2015年

10 程筱雨;血清反應(yīng)因子在帕金森病發(fā)病中的作用和機(jī)制研究[D];蘇州大學(xué);2015年

，

本文編號(hào)：1866281